Zafgen, Inc. (ZFGN) May 29, 2020 - ZFGN merged into
LRMR Stock Price:
$0.990 USD
0.000 (0.00% )
Updated May 28, 2020 4:00 PM EDT
Key Info
Market Cap
37.10M
Revenue (ttm)
n/a
Net Income (ttm)
-35.89M
Shares Out
3.12M
EPS (ttm)
-0.96
PE Ratio
n/a
Forward PE
n/a
Dividend
n/a
Dividend Yield
n/a
Stock Quote
Trading Day
May 28, 2020
Last Price
$0.990
Previous Close
$0.990
Change ($)
0.000
Change (%)
0.00%
Day's Open
1.020
Day's Range
10.000 - 12.510
Day's Volume
4,323,149
52-Week Range
0.619 - 12.510
More Stats
Market Cap
37.10M
Enterprise Value
n/a
Earnings Date (est)
n/a
Ex-Dividend Date
n/a
Shares Outstanding
3.12M
Float
16.52M
EPS (basic)
-0.97
EPS (diluted)
-0.96
FCF / Share
-0.92
Dividend
n/a
Dividend Yield
n/a
Earnings Yield
n/a
FCF Yield
n/a
Payout Ratio
n/a
Shares Short
523,135
Short Ratio
2.48
Short % of Float
1.69%
Beta
0.27
PE Ratio
n/a
Forward PE
n/a
P/FCF Ratio
n/a
PS Ratio
n/a
PB Ratio
0.73
Revenue
n/a
Operating Income
-35.94M
Net Income
-35.89M
Free Cash Flow
-34.27M
Net Cash
44.45M
Net Cash / Share
1.19
Gross Margin
n/a
Operating Margin
n/a
Profit Margin
n/a
FCF Margin
n/a
ROA
-20.65%
ROE
-53.93%
ROIC
-56.90%
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (0)
Buy
0
Overweight
0
Hold
0
Underweight
0
Sell
0
Low
9.36
Current: $0.990
High
9.36
Target: 9.36
*Average 12-month price target from 1 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
Year 2019 2018 2017 2016 2015 2014 2013 2012 Revenue - - - - - - - - Operating Income -45.65 -61.12 -53.00 -58.23 -73.81 -35.53 -13.78 -13.79 Net Income -45.41 -61.37 -52.03 -57.88 -74.29 -36.48 -14.03 -13.88 Shares Outstanding 37.35 32.23 27.43 27.30 26.76 12.19 0.73 0.71 Earnings Per Share -1.22 -1.90 -1.90 -2.12 -2.78 -3.00 -19.53 -19.65 Operating Cash Flow -40.78 -51.49 -43.78 -51.98 -59.55 -28.24 -15.00 -13.59 Capital Expenditures -1.35 -0.11 -0.06 -0.66 -0.60 -0.06 -0.02 - Free Cash Flow -42.13 -51.60 -43.84 -52.64 -60.15 -28.30 -15.02 -13.59 Cash & Equivalents 71.60 118 102 129 185 115 35.52 0.00 Total Debt 22.58 20.64 20.00 3.59 6.39 7.56 - - Net Cash / Debt 49.02 97.43 82.05 126 179 108 35.52 0.00 Assets 80.73 122 106 132 189 118 38.14 - Liabilities 27.11 28.49 27.29 9.89 20.00 13.08 2.92 - Book Value 53.62 93.27 78.22 122 169 104 -68.57 -
Numbers in millions USD, except per-share numbers.
Company Details
Full Name
Zafgen, Inc.
Country
United States
Employees
7
CEO
Jeffrey S. Hatfield
Stock Information
Ticker Symbol
ZFGN
Stock Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology
Unique Identifier
NASDAQ: ZFGN
IPO Date
June 19, 2014
Description
Zafgen, Inc., a clinical-stage biopharmaceutical company, develops methionine aminopeptidase 2 inhibitors for common and rare metabolic disorders. The company was founded in 2005 and is headquartered in Boston, Massachusetts.